report
Japan delays medical expense reforms amidst political pushback
Japan delays medical expense reforms amidst political pushback
Overall health spending is still expected to surpass 12% of GDP by 2029.
1 day ago
Health information exchange market to reach $4.44b by 2032
Thanks to a rising focus on interoperability and seamless data sharing.
1 day ago
Global venipuncture procedure market to hit $1.5b by 2030
Its growth is attributed to the increasing demand for diagnostic testing.
1 day ago
Single-use surgical instruments market to reach $7.8b by 2030
Thanks to the rise of minimally invasive, short-stay, and outpatient surgeries.
4 days ago
Endometriosis market across the 7MM to hit $2.5b by 2034
Its expansion is attributed to the introduction of several key therapies.
4 days ago
Pakistan’s drug import dependence poses risks to critical medicine supply
Pharmaceutical imports are expected to reach $920m by 2029.
5 days ago
Endoscopic hemostasis devices market eyes 3.6% CAGR growth through 2034
Ageing populations are undergoing more frequent endoscopic screenings.
5 days ago
Remote surgery technology platforms market to hit $10.52b by 2034
Its growth is attributed to the rising demand for minimally invasive surgeries.
5 days ago
Residual DNA testing market to be valued at $370m by 2030
India, China, Brazil, and Japan are rapidly scaling their biopharma capabilities.
5 days ago
UAE’s growing cancer burden raises concerns over health system capacity
One key challenge is the workforce shortage.
Self-service kiosks for healthcare market to reach $3.77b by 2034
There is a growing adoption in hospitals, clinics, and pharmacies.
Global ophthalmology drugs market to hit $26.28b by 2030
Investments, strategic collaborations, and therapy advancements drive growth.
7MM multiple sclerosis-diagnosed cases to reach 1.64 million by 2033
Japan is expected to have the lowest count at 31,527 cases.
APAC eyes fastest growth in global cardiovascular information system market
Thanks to rapid urbanisation and increased healthcare spending.
Global cancer immunotherapy market to be valued at $247.2b by 2029
Developments in genomics, AI, and biotechnology are driving market growth.
Australia’s nuclear imaging agents market to hit $30m by 2036
Its growth is driven by a rise in prostate cancer cases.
Liver disease treatment market to be valued at $69.1b by 2030
Personalised medicine and fibrosis-targeting treatments are key growth areas.
Most Read
1. Here’s what’s challenging the HIV market 2. New 300-bed multispeciality hospital opens in Banjara Hills, India 3. Singapore adds special care dentistry as eighth dental speciality 4. Australia invests $1.2b to cut Queensland’s elective surgery waiting times 5. Fortis Hospital launches dual-robot programme for kidney transplantResource Center
Read Here
Advertise
Sign Up
Event News
The medical institution earned recognition for its National Hospital Apps which have brought digital revolution in healthcare.
Commentary
Biomedical textiles: Novel fabrics supporting enhanced patient care in Asia-Pacific